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Diversity-oriented synthesis and the development of novel
antimalarials
Malaria is widely recognised as a major threat to human health,
but despite the urgency in ﬁnding novel antimalarial compounds,
no new class of agent has been introduced into clinical use since
1996. The need becomes even more acute when the recent
emergence of drug-resistant strains is considered. A recent paper
describes the diversity-oriented synthesis of macrocyclic antima-
larial agents, and demonstrates how comprehensive structural
modiﬁcation resulted in a compound with improved physical
properties [1].
In a previous study a library approach to making macrocycles
involved building diverse building blocks, coupling these into lin-
ear precursors and a ﬁnal pairing of functionality to produce cyclic
products – a so-called build/couple/pair approach. Macrocycles
prepared using this strategy were found to have antimalarial prop-
erties, and compound 1 in particular has potent activity against
both wild type 3D7 and multidrug resistant D2d strains of Plasmo-
dium falciparum. However, analysis of this compound revealed a
potential hERG liability and poor mouse microsome stability as
well as poor solubility, making it unsuitable for further develop-
ment. This recent study further investigated this series of macrocy-
cles with the intention of improving these physical properties.
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The macrocycle contains three positions that can readily be
diversiﬁed – the exocyclic dimethylamino group (R1), the aniline-
based urea (R2), and the exocyclic sulphonamide (2). The approach
focused on the ﬁrst two of these, as it had been previously
demonstrated that the sulphonamide was essential for antimalarial
activity. In addition, the build/couple/pair strategywas employed to
investigate the contributions made by the rest of the molecule and
thus identify the minimum pharmacophore required for activity.http://dx.doi.org/10.1016/j.comche.2014.11.001
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Ultimately through these structural changes it was possible to
develop the structure–activity relationships of this series, and
simultaneously proﬁle compounds for hERG activity and physical
properties. Ultimately, compound 3 was selected for in vivo proﬁl-
ing in a Plasmodium berghei malaria mouse model. The goal was to
ﬁnd a compound that has exposure in vivo exceeding three times
the GI50 concentration. Intraperitoneal administration of com-
pound 3 at 20 mg/kg demonstrated that sufﬁcient exposure could
be achieved for around 5 h. Administering the compound seven
times at 100 mg/kg every 12 h over 3 days in the P. bergheimalaria
mouse model produced a twofold reduction in total parasitemia.
Although a signiﬁcant reduction, this is not quite at the levels seen
with standard of care antimalarial compounds and thus more com-
pound development is still required.
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Overall, this study was successful in using diversity-oriented
synthesis to explore SAR and physical properties, and in ﬁnding a
potent antimalarial compound with some level of exposure and
efﬁcacy in a malarial mouse model.
A summary of the papers in this month’s issue
Polymer supported synthesis
A facile and expedient route to the synthesis of arylopeptoid
oligomers (N-alkylated aminomethyl benzamides) using a semi-
automated microwave-assisted solid-phase synthesis has been
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side chains derived from sterically hindered or unreactive amines
and both ortho- and para-substituted arylo-backbones. By using
this optimised protocol, a complex nonameric arylopeptoid, featur-
ing a novel alternating ortho-, meta-, and para-substituted back-
bone pattern and a variety of chemically diverse and challenging
side chains has been synthesised in less than 11 h [2].
A one-bead-two-compound (OBTC) library of structurally rigid-
iﬁed bicyclic peptides has been chemically synthesised on Tenta-
Gel microbeads (90 lm), with each bead displaying a unique
bicyclic peptide on its surface and a linear encoding peptide of
the same sequence in its interior. Screening of the library against
oncogenic K-Ras G12Vmutant identiﬁed two classes of Ras ligands.
Class I ligands apparently bind to the effector-binding site and
inhibit the Ras–Raf interaction, whereas class II ligands appear to
bind to a yet unidentiﬁed site different from the effector-binding
site. These Ras ligands provide useful research tools and may be
further developed into therapeutic agents [3].
Nobilamide B is a long-acting antagonist of transient receptor
potential vanilloid-1, and is expected to show therapeutic potential
for treatment of pain. This linear heptapeptide possesses a Z-dide-
hydroaminobutanoic acid moiety at the C-terminus that could be
stereoselectively constructed by application of the traceless Stau-
dinger ligation. Combining solid-phase peptide synthesis and the
Staudinger ligation allowed rapid access to not only nobilamide
B, but also its macrocyclic analogue nobilamide D [4].
Solution-phase synthesis
A simple, convenient and efﬁcient protocol for the construction
of an array of glycospiro-pyrroloisoquinolines using isoquinolini-
um ylide and a carbohydrate-derived exocyclic oleﬁn in the pres-
ence of a Cu(OTf)2–Et3N catalytic system has been described.
Isoquinoline and alkylbromoacetates/2-bromoacetophenones
were employed to generate the azomethine ylides in the presence
of Et3N in reﬂuxing toluene, and subsequent exposure to the oleﬁn
led to the desired isoquinoline derivatives [5].
Scaffolds and synthons for combinatorial libraries
No papers this month.
Solid-phase supported reagents
A simple and efﬁcient synthetic protocol for the synthesis of 5-
substituted 1H-tetrazole derivatives through the [2+3] cycloaddi-
tion of nitriles with sodium azide using ceric ammonium nitrate
supported HY-zeolite as a novel catalyst has been reported. Excel-
lent yields of the corresponding tetrazoles were obtained through
this cost-effective protocol under mild aerobic reaction conditions
with short reaction times [6].
An efﬁcient and ecofriendly aldol reaction of kojic acid with
aldehydes using a heterogeneous reusable catalyst (alumina mod-
iﬁed with base) has been developed. Enzymatic hydrolytic resolu-
tion of a racemic acetylated aldol adduct was achieved using lipase
from Candida Antarctica type B. The key feature of this enzymatic
resolution is that regioselective deacetylation of the ester, derived
from a primary alcohol located away from the stereocentre,
occurred in the presence of an adjacent secondary acetate [7].
Novel resins, linkers and techniques
An alkoxyamine linker has been applied for the solid-phase syn-
thesis of benzazoles, quinazolines, and quinazolinones. Aromatic
aldehydes were anchored by aldoxime linkage, and after reaction
on a solid support, the products were cleaved with paraformalde-hyde under acidic conditions to afford the corresponding alde-
hydes. These were subsequently subjected to oxidative coupling
with 2-substituted anilines under air atmosphere to give the
desired compounds [8].
Library applications
Phenyl imidazolidin-2-one has been introduced as a linker for
novel HDAC inhibitors. A focused library of 20 compounds were
designed and synthesised, from which eight compounds showed
equivalent or higher potencies against HDAC1 than vorinostat. In
vitro antitumor activity assays in HCT-116, PC-3 and HL-60 cancer
cells revealed six compounds with potent antitumor activities. In
an HCT-116 nude mice xenograft model, one compound displayed
signiﬁcant antitumour activity in both continuous and intermittent
dosing schedules [9].
A small library of benzimidazole functionalised chiral thioureas
has been prepared starting from natural amino acids (S)-alanine,
(S)-phenylalanine, (S)-valine and (S)-leucine and also their (R)-iso-
mers Their antimicrobial activity against various Gram-positive
and Gram-negative bacterial strains such as Staphylococcus aureus,
Bacillus subtilis, Micrococcus luteus, Klebsiella planticola, Escherichia
coli and Pseudomonas aeruginosa have been investigated. In a cyto-
toxicity study, thioureas derived from non-natural amino acids
showed good activity against human cancer cell lines A549,
MCF7, DU145, and HeLa [10].
Histidinol dehydrogenase (HDH) has been established as a vir-
ulence factor for the human pathogen bacterium Brucella suis. Tar-
geting such a virulence factor is a relevant anti-infectious approach
as it could decrease the frequency of antibiotic resistance. The syn-
thesis of a library of oxo- and thioxo-imidazo[1,5-c]pyrimidines,
potential enzyme inhibitors of HDH, has been described in a recent
paper [11].
A water-mediated protocol for the efﬁcient synthesis of a
library of 2-amino-6-styryl pyrimidines and their dihydro ana-
logues has been reported. Most of the saturated compounds rather
than their unsaturated analogues showed anti-bacterial (in vitro)
activity against three human pathogens viz. S. aureus, Klebsiella
pneumonia and E. coli [12].
Aminoglycoside-200-O-nucleotidyltransferase ANT(200)-Ia is an
aminoglycoside resistance enzyme prevalent among Gram-nega-
tive bacteria, and is one of the most common determinants of
enzyme-dependant aminoglycoside-resistance. A recent paper out-
lines the use of a recently described oxidopyrylium cycloaddition/
ring-opening strategy in the synthesis and proﬁling of a library of
synthetic a-hydroxytropolones against ANT(200)-Ia. Two of these
synthetic constructs are capable of rescuing gentamicin activity
against ANT-(200)-Ia-expressing bacteria [13].
On-going SAR efforts based on ML297, a potent, efﬁcacious and
selective GIRK1/2 activator (10-fold vs GIRK1/4 and inactive on
GIRK2/3), being investigated via an iterative parallel synthesis
approach have been reported. The chemical optimisation at the
3-position of the pyrazole within ML297 indicated that various
functionalised 3-cyclopropyl moieties modulated GIRK pharmacol-
ogy between inhibitor/activator within a series of 1-(3-cyclopro-
pyl-1-phenyl-1H-pyrazol-5-yl)ureas. Importantly, novel
‘molecular switches’ that modulated the mode of pharmacology
from inhibitor to activator have been discovered on both the 3-
cyclopropyl and N-phenyl moiety of the pyrazole core, providing
the ﬁrst highly selective GIRK1/2 activator [14].
The presence of a structural recognition motif for the nucleoside
P2 transporter in a library of pyrimidine and triazine non-nucleo-
side HIV-1 reverse transcriptase inhibitors, has prompted the eval-
uation of antitrypanosomal activity. It has been demonstrated that
the structure–activity relationship for anti-HIV and antitrypanoso-
mal activity was not identical. Optimisation in the diaryl triazine
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a compound with potent in vitro and moderate in vivo antitrypan-
osomal activity [15].
A polymer-supported route for the synthesis of sphingosine
derivatives based on the C-acylation of polymeric phosphoranylid-
ene acetates with an Fmoc-protected amino acid has been pre-
sented. The approach enables the ﬂexible variation of the
sphingosine tail through a deprotection–decarboxylation sequence
followed by E-selective Wittig oleﬁnation cleavage. The effect of
ceramides and keto-ceramides on the proliferation of three cancer
cell lines HEP G-2, PC-12 and HL-60 was investigated and a cera-
mide containing an aromatic sphingosine tail was identiﬁed as
being most active [16].
In order to develop afﬁnity-based biosensor platforms, appro-
priate ligands with a functional handle for immobilisation onto a
biosensor surface are required. To this end, a library of papain
inhibitors has been designed and synthesised, containing different
azide linkers for subsequent immobilisation by ‘click’ chemistry.
Furthermore, a molecular docking study was performed to obtain
a better insight as to at which position such azide handles could
be tolerated without affecting binding afﬁnity [17].
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